Section |
|
Latest Transmittal |
DI 23022.010 |
Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track
Processes
|
TN 56 05-23 |
DI 23022.030 |
Identifying and Receipting Compassionate Allowances (CAL) and Quick Disability Determinations
(QDD) Cases
|
TN 24 02-19 |
DI 23022.040 |
Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track
Case Development
|
TN 56 05-23 |
DI 23022.050 |
Making the Determination in Compassionate Allowances (CAL) or Quick Disability Determinations
(QDD) Fast-Track Cases
|
TN 18 11-18 |
DI 23022.055 |
Adding and Modifying Compassionate Allowances (CAL) Status; Removing and Reinstating
CAL and Quick Disability Determinations (QDD) Status
|
TN 71 07-24 |
DI 23022.060 |
Disability Determination Services Jurisdiction When a Compassionate Allowances or
Quick Disability Determinations Claimant Moves to another State or Leaves the United
States
|
TN 24 02-19 |
DI 23022.075 |
Appeals Processing of Compassionate Allowances (CAL) Cases |
TN 24 02-19 |
DI 23022.080 |
List of Compassionate Allowances (CAL) Conditions |
TN 73 08-24 |
DI 23022.081 |
1p36 Deletion Syndrome |
TN 57 08-23 |
DI 23022.082 |
Adult Heart Transplant Wait List – Status Levels 1-4 |
TN 73 08-24 |
DI 23022.085 |
Acute Leukemia |
TN 35 08-20 |
DI 23022.090 |
Adrenal Cancer with Distant Metastases or Inoperable, Unresectable or Recurrent |
TN 60 10-23 |
DI 23022.095 |
Alexander Disease - Child |
TN 54 09-22 |
DI 23022.100 |
Amyotrophic Lateral Sclerosis (ALS) - ADULT |
TN 69 12-23 |
DI 23022.105 |
Anaplastic Adrenal Cancer - Adult with Distant Metastases or Inoperable, Unresectable
or Recurrent
|
TN 61 10-23 |
DI 23022.106 |
Angiosarcoma |
TN 54 09-22 |
DI 23022.110 |
Astrocytoma - Grade III and IV |
TN 54 09-22 |
DI 23022.111 |
Atypical Teratoid/Rhabdoid Tumor |
TN 54 09-22 |
DI 23022.112 |
Bainbridge-Ropers Syndrome |
TN 73 08-24 |
DI 23022.115 |
Bladder Cancer with Distant Metastases or Inoperable or Unresectable |
TN 61 10-23 |
DI 23022.117 |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
TN 53 08-22 |
DI 23022.120 |
Osteosarcoma, formerly known as Bone Cancer |
TN 60 10-23 |
DI 23022.125 |
Breast Cancer – with Distant Metastases or Recurrent |
TN 61 10-23 |
DI 23022.127 |
CACH - Vanishing White Matter Disease - Congenital, Infantile, and Early Childhood
Onset Forms
|
TN 34 08-20 |
DI 23022.128 |
Calciphylaxis |
TN 57 08-23 |
DI 23022.130 |
Canavan Disease |
TN 54 09-22 |
DI 23022.133 |
CDKL5 Deficiency Disorder |
TN 54 09-22 |
DI 23022.135 |
Cerebro Oculo Facio Skeletal (COFS) Syndrome |
TN 35 08-20 |
DI 23022.136 |
Chronic Idiopathic Intestinal Pseudo Obstruction |
TN 54 09-22 |
DI 23022.140 |
Chronic Myelogenous Leukemia (CML) - Blast Phase |
TN 35 08-20 |
DI 23022.141 |
Coffin-Lowry Syndrome |
TN 34 08-20 |
DI 23022.143 |
Congenital Myotonic Dystrophy |
TN 56 05-23 |
DI 23022.144 |
Charlevoix-Saguenay Spastic Ataxia |
TN 54 09-22 |
DI 23022.145 |
Creutzfeldt-Jakob Disease (CJD) |
TN 54 09-22 |
DI 23022.146 |
Desmoplastic Small Round Cell Tumors |
TN 37 09-20 |
DI 23022.150 |
Ependymoblastoma (Child Brain Cancer) |
TN 54 09-22 |
DI 23022.155 |
Esophageal Cancer |
TN 54 09-22 |
DI 23022.156 |
Esthesioneuroblastoma |
TN 35 08-20 |
DI 23022.160 |
Farber's Disease |
TN 34 08-20 |
DI 23022.163 |
Fibrolamellar Cancer |
TN 54 09-22 |
DI 23022.165 |
Friedreich's Ataxia (FRDA) |
TN 34 08-20 |
DI 23022.170 |
Frontotemporal Dementia (FTD), Pick's Disease - Type A - Adult |
TN 69 12-23 |
DI 23022.175 |
Gallbladder Cancer |
TN 35 08-20 |
DI 23022.180 |
Gaucher Disease (GD) - Type 2 |
TN 54 09-22 |
DI 23022.181 |
Giant Axonal Neuropathy |
TN 34 08-20 |
DI 23022.185 |
Glioblastoma Multiforme (Adult Brain Cancer) |
TN 61 10-23 |
DI 23022.186 |
GM1 - Gangliosidosis - Infantile & Juvenile Forms |
TN 54 09-22 |
DI 23022.190 |
Head and Neck Cancers - with Distant Metastasis or Inoperable or Unresectable |
TN 61 10-23 |
DI 23022.191 |
Hoyeraal-Hreidarsson Syndrome |
TN 34 08-20 |
DI 23022.195 |
Infantile Neuroaxonal Dystrophy (INAD) |
TN 34 08-20 |
DI 23022.200 |
Inflammatory Breast Cancer |
TN 35 08-20 |
DI 23022.201 |
Intracranial Hemangiopericytoma |
TN 35 08-20 |
DI 23022.202 |
Joubert Syndrome |
TN 34 08-20 |
DI 23022.205 |
Kidney Cancer - Inoperable or Unresectable |
TN 61 10-23 |
DI 23022.207 |
Kleefstra Syndrome |
TN 34 08-20 |
DI 23022.210 |
Krabbe Disease (KD) - Infantile |
TN 34 08-20 |
DI 23022.215 |
Large Intestine Cancer - with Distant Metastasis or Inoperable, Unresectable or Recurrent |
TN 61 10-23 |
DI 23022.216 |
Leptomeningeal Carcinomatosis |
TN 54 09-22 |
DI 23022.220 |
Lesch-Nyhan Syndrome (LNS) |
TN 56 05-23 |
DI 23022.221 |
Liposarcoma - Metastatic or Recurrent |
TN 54 09-22 |
DI 23022.225 |
Hepatocellular Carcinoma |
TN 54 09-22 |
DI 23022.226 |
Malignant Ectomesenchymoma |
TN 54 09-22 |
DI 23022.227 |
Malignant Renal Rhabdoid Tumor |
TN 35 08-20 |
DI 23022.230 |
Mantle Cell Lymphoma (MCL) |
TN 52 06-22 |
DI 23022.231 |
Marshall-Smith Syndrome |
TN 35 08-20 |
DI 23022.233 |
Megacystis Microcolon Intestinal Hypoperistalsis Syndrome |
TN 35 08-20 |
DI 23022.234 |
Megalencephaly-Capillary Malformation Syndrome |
TN 35 08-20 |
DI 23022.235 |
Metachromatic Leukodystrophy (MLD) - Late Infantile |
TN 69 12-23 |
DI 23022.236 |
Nicolaides-Baraitser Syndrome |
TN 28 08-20 |
DI 23022.238 |
SYNGAP1-related NSID |
TN 45 08-21 |
DI 23022.240 |
Niemann-Pick Disease (NPD) - Type A |
TN 35 08-20 |
DI 23022.245 |
Non-Small Cell Lung Cancer |
TN 35 08-20 |
DI 23022.246 |
Oligodendroglioma Brain Cancer - Grade III |
TN 54 09-22 |
DI 23022.250 |
Ornithine Transcarbamylase (OTC) Deficiency |
TN 54 09-22 |
DI 23022.255 |
Osteogenesis Imperfecta (OI) - Type II |
TN 35 08-20 |
DI 23022.260 |
Ovarian Cancer - with Distant Metastases or Inoperable or Unresectable |
TN 60 10-23 |
DI 23022.261 |
Pallister-Killian Syndrome |
TN 34 08-20 |
DI 23022.265 |
Pancreatic Cancer |
TN 33 08-20 |
DI 23022.266 |
Pericardial Mesothelioma |
TN 45 08-21 |
DI 23022.270 |
Peritoneal Mesothelioma |
TN 54 09-22 |
DI 23022.273 |
Pineoblastoma – Childhood |
TN 57 08-23 |
DI 23022.274 |
Plasmablastic Lymphoma |
TN 73 08-24 |
DI 23022.275 |
Pleural Mesothelioma |
TN 33 08-20 |
DI 23022.280 |
Pompe Disease - Infantile |
TN 34 08-20 |
DI 23022.281 |
Progressive Bulbar Palsy |
TN 34 08-20 |
DI 23022.282 |
Prostate Cancer – Hormone Refractory Disease – or with Visceral Metastases |
TN 60 10-23 |
DI 23022.283 |
Refractory Hodgkin Lymphoma |
TN 45 08-21 |
DI 23022.284 |
Renpenning Syndrome |
TN 54 09-22 |
DI 23022.285 |
Rett Syndrome (RTT) |
TN 34 08-20 |
DI 23022.286 |
Revesz Syndrome |
TN 54 09-22 |
DI 23022.287 |
Rubinstein-Taybi Syndrome |
TN 28 08-20 |
DI 23022.290 |
Salivary Cancers |
TN 33 08-20 |
DI 23022.295 |
Sandhoff Disease |
TN 33 08-20 |
DI 23022.296 |
Seckel Syndrome |
TN 34 08-20 |
DI 23022.297 |
Sjögren-Larsson Syndrome |
TN 64 10-23 |
DI 23022.298 |
Secondary Adenocarcinoma of the Brain |
TN 40 10-20 |
DI 23022.300 |
Small Cell Cancer of the Large Intestine |
TN 54 09-22 |
DI 23022.305 |
Small Cell Cancer of the Ovary |
TN 36 09-20 |
DI 23022.310 |
Small Cell Cancer of the Prostate |
TN 36 09-20 |
DI 23022.311 |
Small Cell Cancer of the Thymus |
TN 36 09-20 |
DI 23022.315 |
Small-Cell Cancer of the Female Genital Tract |
TN 60 10-23 |
DI 23022.320 |
Small Cell Lung Cancer |
TN 36 09-20 |
DI 23022.325 |
Small Intestine Cancer - with Distant Metastases or Inoperable or Recurrent |
TN 60 10-23 |
DI 23022.326 |
Soft Tissue Sarcoma - with Distant Metastases or Recurrent |
TN 60 10-23 |
DI 23022.330 |
Spinal Muscular Atrophy (SMA) - Types 0 and 1 |
TN 40 10-20 |
DI 23022.335 |
Stomach Cancer, with Distant Metastases or Inoperable, Unresectable or Recurrent |
TN 60 10-23 |
DI 23022.337 |
Superficial Siderosis of the Central Nervous System |
TN 36 09-20 |
DI 23022.340 |
Anaplastic Thyroid Cancer |
TN 60 10-23 |
DI 23022.341 |
Taybi-Linder Syndrome |
TN 47 08-21 |
DI 23022.343 |
Tetrasomy 18p |
TN 36 09-20 |
DI 23022.344 |
Trisomy 9 |
TN 57 08-23 |
DI 23022.345 |
Ureter Cancer - with Metastases or Inoperable, Unresectable or Recurrent |
TN 60 10-23 |
DI 23022.346 |
X-Linked Lymphoproliferative Disease |
TN 36 09-20 |
DI 23022.347 |
X-Linked Myotubular Myopathy |
TN 49 10-21 |
DI 23022.350 |
Alstrom Syndrome |
TN 31 08-20 |
DI 23022.355 |
Amegakaryocytic Thrombocytopenia |
TN 56 05-23 |
DI 23022.357 |
Angioimmunoblastic T-Cell Lymphoma |
TN 53 08-22 |
DI 23022.360 |
Ataxia Telangiectasia |
TN 38 09-20 |
DI 23022.365 |
Batten Disease |
TN 40 10-20 |
DI 23022.370 |
Bilateral Retinoblastoma |
TN 31 08-20 |
DI 23022.373 |
Congenital Zika Syndrome |
TN 47 08-21 |
DI 23022.374 |
Costello Syndrome |
TN 73 08-24 |
DI 23022.375 |
Cri du Chat Syndrome |
TN 40 10-20 |
DI 23022.380 |
Degos Disease - Systemic |
TN 31 08-20 |
DI 23022.382 |
Desmoplastic Mesothelioma |
TN 45 08-21 |
DI 23022.385 |
Early-Onset Alzheimer's Disease |
TN 38 09-20 |
DI 23022.390 |
Edwards Syndrome (Trisomy 18) |
TN 69 12-23 |
DI 23022.395 |
Fibrodysplasia Ossificans Progressiva |
TN 49 10-21 |
DI 23022.400 |
Fukuyama Congenital Muscular Dystrophy |
TN 40 10-20 |
DI 23022.403 |
Gerstmann-Straussler-Scheinker Disease |
TN 53 08-22 |
DI 23022.405 |
Hemophagocytic Lymphohistiocytosis - Familial Type (FHLH) |
TN 66 11-23 |
DI 23022.407 |
Histiocytic Malignancies |
TN 73 08-24 |
DI 23022.410 |
MPS II |
TN 69 12-23 |
DI 23022.415 |
MPS I |
TN 69 12-23 |
DI 23022.420 |
Idiopathic Pulmonary Fibrosis |
TN 35 08-20 |
DI 23022.425 |
Infantile Neuronal Ceroid Lipofuscinoses |
TN 68 12-23 |
DI 23022.430 |
Junctional Epidermolysis Bullosa - Lethal Type |
TN 68 12-23 |
DI 23022.435 |
Late Infantile Neuronal Ceroid Lipofuscinoses |
TN 68 12-23 |
DI 23022.437 |
Leber Congenital Amaurosis |
TN 57 08-23 |
DI 23022.440 |
Leigh's Disease |
TN 35 08-20 |
DI 23022.445 |
Maple Syrup Urine Disease |
TN 38 09-20 |
DI 23022.450 |
Merosin Deficient Congenital Muscular Dystrophy |
TN 40 10-20 |
DI 23022.453 |
Microvillus Inclusion Disease – Child |
TN 53 08-22 |
DI 23022.455 |
Mixed Dementias |
TN 38 09-20 |
DI 23022.457 |
Mowat-Wilson Syndrome |
TN 53 08-22 |
DI 23022.460 |
Mucosal Malignant Melanoma |
TN 32 08-20 |
DI 23022.463 |
Myelodysplastic Syndrome with Excess Blasts |
TN 53 08-22 |
DI 23022.465 |
Neonatal Adrenoleukodystrophy |
TN 32 08-20 |
DI 23022.468 |
Neonatal Marfan Syndrome |
TN 73 08-24 |
DI 23022.470 |
Glutaric Acidemia - Type II |
TN 61 10-23 |
DI 23022.475 |
Niemann-Pick Disease - Type C |
TN 32 08-20 |
DI 23022.477 |
NUT Carcinoma |
TN 53 08-22 |
DI 23022.480 |
Patau Syndrome (Trisomy 13) |
TN 33 08-20 |
DI 23022.481 |
Pfeiffer Syndrome - Types II and III |
TN 53 08-22 |
DI 23022.482 |
Pontocerebellar Hypoplasia |
TN 53 08-22 |
DI 23022.483 |
Primary Peritoneal Cancer |
TN 33 08-20 |
DI 23022.485 |
Primary Progressive Aphasia |
TN 54 09-22 |
DI 23022.490 |
Progressive Multifocal Leukoencephalopathy |
TN 40 10-20 |
DI 23022.495 |
MPS III |
TN 69 12-23 |
DI 23022.496 |
SCN8A-related Epilepsy with Encephalopathy |
TN 45 08-21 |
DI 23022.500 |
Spinocerebellar Ataxia |
TN 36 09-20 |
DI 23022.503 |
Snijders Blok-Campeau Syndrome |
TN 73 08-24 |
DI 23022.505 |
Subacute Sclerosing Panencephalitis |
TN 54 09-22 |
DI 23022.510 |
Tay Sachs Disease, Infantile Type |
TN 36 09-20 |
DI 23022.515 |
Thanatophoric Dysplasia, Type 1 |
TN 36 09-20 |
DI 23022.520 |
Ullrich Congenital Muscular Dystrophy |
TN 38 09-20 |
DI 23022.525 |
Walker Warburg Syndrome |
TN 36 09-20 |
DI 23022.530 |
Wolman Disease |
TN 36 09-20 |
DI 23022.535 |
Zellweger Syndrome |
TN 36 09-20 |
DI 23022.536 |
Anaplastic Ependymoma |
TN 57 08-23 |
DI 23022.540 |
Aortic Atresia |
TN 31 08-20 |
DI 23022.543 |
CIC-rearranged Sarcoma |
TN 47 08-21 |
DI 23022.545 |
Eisenmenger Syndrome |
TN 31 08-20 |
DI 23022.550 |
Endomyocardial Fibrosis |
TN 31 08-20 |
DI 23022.555 |
Heart Transplant Graft Failure |
TN 32 08-20 |
DI 23022.560 |
Child Heart Transplant Wait List - Status Levels 1A/1B |
TN 73 08-24 |
DI 23022.565 |
Hypoplastic Left Heart Syndrome |
TN 32 08-20 |
DI 23022.570 |
Ventricular Assist Device Recipient — Left, Right, or Biventricular |
TN 36 09-20 |
DI 23022.575 |
Mitral Valve Atresia |
TN 32 08-20 |
DI 23022.580 |
Cardiac Amyloidosis - AL Type |
TN 31 08-20 |
DI 23022.585 |
Pulmonary Atresia |
TN 33 08-20 |
DI 23022.586 |
Sarcomatoid Carcinoma of the Lung—Stages II-IV |
TN 57 08-23 |
DI 23022.587 |
Sarcomatoid Mesothelioma |
TN 53 08-22 |
DI 23022.590 |
Single Ventricle |
TN 33 08-20 |
DI 23022.595 |
Tricuspid Atresia |
TN 36 09-20 |
DI 23022.600 |
Angelman Syndrome |
TN 38 09-20 |
DI 23022.605 |
Corticobasal Degeneration |
TN 38 09-20 |
DI 23022.610 |
Lewy Body Dementia |
TN 72 08-24 |
DI 23022.615 |
Lowe Syndrome |
TN 35 08-20 |
DI 23022.620 |
Malignant Multiple Sclerosis |
TN 38 09-20 |
DI 23022.625 |
Multicentric Castleman Disease |
TN 38 09-20 |
DI 23022.630 |
Multiple System Atrophy |
TN 39 10-20 |
DI 23022.633 |
Paraneoplastic Cerebellar Degeneration |
TN 57 08-23 |
DI 23022.635 |
Paraneoplastic Pemphigus |
TN 62 10-23 |
DI 23022.640 |
Primary Central Nervous System Lymphoma |
TN 33 08-20 |
DI 23022.643 |
Posterior Cortical Atrophy |
TN 53 08-22 |
DI 23022.645 |
Primary Effusion Lymphoma |
TN 33 08-20 |
DI 23022.647 |
Primary Omental Cancer |
TN 57 08-23 |
DI 23022.650 |
Progressive Supranuclear Palsy |
TN 33 08-20 |
DI 23022.655 |
Pulmonary Kaposi Sarcoma |
TN 54 09-22 |
DI 23022.660 |
ALS/Parkinsonism Dementia Complex |
TN 69 12-23 |
DI 23022.665 |
Aicardi--Goutieres Syndrome |
TN 30 08-20 |
DI 23022.670 |
Alobar Holoprosencephaly |
TN 43 10-20 |
DI 23022.675 |
Alpers Disease |
TN 30 08-20 |
DI 23022.680 |
Alpha Mannosidosis--Types II and III |
TN 69 12-23 |
DI 23022.685 |
Carcinoma of Unknown Primary Site |
TN 35 08-20 |
DI 23022.690 |
Cerebrotendinous Xanthomatosis |
TN 30 08-20 |
DI 23022.695 |
Child Neuroblastoma—with distant metastases or recurrent |
TN 35 08-20 |
DI 23022.700 |
Child Lymphoma |
TN 35 08-20 |
DI 23022.704 |
Cholangiocarcinoma |
TN 57 08-23 |
DI 23022.705 |
Chondrosarcoma—with multimodal therapy |
TN 35 08-20 |
DI 23022.710 |
Cornelia de Lange Syndrome--Classic Form |
TN 35 08-20 |
DI 23022.715 |
Ewing Sarcoma |
TN 35 08-20 |
DI 23022.720 |
Follicular Dendritic Cell Sarcoma -- metastatic or recurrent |
TN 35 08-20 |
DI 23022.723 |
FOXG1 Syndrome |
TN 57 08-23 |
DI 23022.725 |
Fucosidosis -- Type I |
TN 35 08-20 |
DI 23022.730 |
Galactosialidosis -- Early and Late Infantile Types |
TN 35 08-20 |
DI 23022.735 |
Glioma - Grade III and IV |
TN 35 08-20 |
DI 23022.745 |
Hepatoblastoma |
TN 32 08-20 |
DI 23022.750 |
Histiocytosis Syndromes |
TN 73 08-24 |
DI 23022.755 |
Hutchinson-Gilford Progeria Syndrome |
TN 32 08-20 |
DI 23022.760 |
Hydranencephaly |
TN 32 08-20 |
DI 23022.765 |
Hypocomplementemic Urticarial Vasculitis Syndrome |
TN 43 10-20 |
DI 23022.770 |
Hypophosphatasia--Perinatal (Lethal) and Infantile Onset Types |
TN 32 08-20 |
DI 23022.775 |
I Cell Disease |
TN 32 08-20 |
DI 23022.780 |
Infantile Free Sialic Acid Storage Disease |
TN 32 08-20 |
DI 23022.785 |
Juvenile Onset Huntington Disease |
TN 30 08-20 |
DI 23022.790 |
Kufs Disease -- Type A and B |
TN 68 12-23 |
DI 23022.795 |
Lissencephaly |
TN 30 08-20 |
DI 23022.800 |
Lymphomatoid Granulomatosis -- Grade III |
TN 32 08-20 |
DI 23022.805 |
Malignant Brainstem Gliomas -- Childhood |
TN 32 08-20 |
DI 23022.810 |
Skin Malignant Melanoma with Metastases |
TN 60 10-23 |
DI 23022.815 |
Mastocytosis Type IV |
TN 32 08-20 |
DI 23022.820 |
Child Medulloblastoma |
TN 70 01-24 |
DI 23022.825 |
Merkel Cell Carcinoma – with metastases |
TN 32 08-20 |
DI 23022.827 |
Metastatic Endometrial Adenocarcinoma |
TN 57 08-23 |
DI 23022.830 |
Myoclonic Epilepsy with Ragged Red Fibers Syndrome |
TN 41 10-20 |
DI 23022.835 |
Nephrogenic Systemic Fibrosis |
TN 62 10-23 |
DI 23022.836 |
Neurodegeneration with Brain Iron Accumulation - Types 1 and 2 |
TN 69 12-23 |
DI 23022.840 |
Obliterative Bronchiolitis |
TN 32 08-20 |
DI 23022.845 |
Ohtahara Syndrome |
TN 30 08-20 |
DI 23022.850 |
Orthochromatic Leukodystrophy with Pigmented Glia |
TN 44 11-20 |
DI 23022.853 |
PACS1 Syndrome |
TN 73 08-24 |
DI 23022.855 |
Pearson Syndrome |
TN 33 08-20 |
DI 23022.860 |
Pelizaeus-Merzbacher Disease--Classic Form |
TN 54 09-22 |
DI 23022.865 |
Pelizaeus-Merzbacher Disease--Connatal Form |
TN 30 08-20 |
DI 23022.870 |
Peripheral Nerve Cancer – Metastatic or Recurrent |
TN 60 10-23 |
DI 23022.875 |
Perry Syndrome |
TN 30 08-20 |
DI 23022.877 |
Pitt Hopkins Syndrome |
TN 33 08-20 |
DI 23022.878 |
Renal Amyloidosis – AL Type |
TN 53 08-22 |
DI 23022.879 |
Renal Medullary Carcinoma |
TN 73 08-24 |
DI 23022.880 |
Rhabdomyosarcoma |
TN 33 08-20 |
DI 23022.885 |
Rhizomelic Chondrodysplasia Punctata |
TN 33 08-20 |
DI 23022.887 |
Richter Syndrome |
TN 54 09-22 |
DI 23022.890 |
Schindler Disease -- Type I |
TN 69 12-23 |
DI 23022.895 |
Smith Lemli Opitz Syndrome |
TN 36 09-20 |
DI 23022.900 |
Spinal Nerve Root Cancer – Metastatic or Recurrent |
TN 60 10-23 |
DI 23022.905 |
Stiff Person Syndrome |
TN 30 08-20 |
DI 23022.910 |
Tabes Dorsalis |
TN 30 08-20 |
DI 23022.915 |
Wolf-Hirschhorn Syndrome |
TN 36 09-20 |
DI 23022.920 |
Xeroderma Pigmentosum |
TN 62 10-23 |
DI 23022.921 |
Adult Non-Hodgkin Lymphoma |
TN 31 08-20 |
DI 23022.923 |
Adult Onset Huntington Disease |
TN 54 09-22 |
DI 23022.925 |
Allan-Herndon-Dudley Syndrome |
TN 30 08-20 |
DI 23022.927 |
Alveolar Soft Part Sarcoma |
TN 31 08-20 |
DI 23022.929 |
Aplastic Anemia |
TN 31 08-20 |
DI 23022.931 |
Beta Thalassemia Major |
TN 31 08-20 |
DI 23022.933 |
Bilateral Optic Atrophy - Infantile |
TN 31 08-20 |
DI 23022.935 |
Caudal Regression Syndrome - Types III and IV |
TN 30 08-20 |
DI 23022.937 |
Child Lymphoblastic Lymphoma |
TN 41 10-20 |
DI 23022.938 |
Choroid Plexus Carcinoma |
TN 45 08-21 |
DI 23022.939 |
Congenital Lymphedema |
TN 62 10-23 |
DI 23022.940 |
Duchenne Muscular Dystrophy - Adult |
TN 46 08-21 |
DI 23022.941 |
De Sanctis Cacchione Syndrome |
TN 62 10-23 |
DI 23022.943 |
Dravet Syndrome |
TN 31 08-20 |
DI 23022.945 |
Endometrial Stromal Sarcoma |
TN 31 08-20 |
DI 23022.947 |
Erdheim Chester Disease |
TN 41 10-20 |
DI 23022.949 |
Fatal Familial Insomnia |
TN 30 08-20 |
DI 23022.951 |
Fryns Syndrome |
TN 31 08-20 |
DI 23022.953 |
Fulminant Giant Cell Myocarditis |
TN 31 08-20 |
DI 23022.955 |
Hepatopulmonary Syndrome |
TN 32 08-20 |
DI 23022.957 |
Hepatorenal Syndrome |
TN 32 08-20 |
DI 23022.959 |
Jervell and Lange-Nielsen Syndrome |
TN 32 08-20 |
DI 23022.961 |
Leiomyosarcoma |
TN 32 08-20 |
DI 23022.963 |
Malignant Gastrointestinal Stromal Tumor |
TN 32 08-20 |
DI 23022.965 |
Malignant Germ Cell Tumor |
TN 32 08-20 |
DI 23022.967 |
MECP2 Duplication Syndrome |
TN 30 08-20 |
DI 23022.969 |
Menkes Disease - Classic or Infantile Onset Form |
TN 32 08-20 |
DI 23022.971 |
NFU-1 Mitochondrial Disease |
TN 32 08-20 |
DI 23022.973 |
Nonketotic Hyperglycinemia |
TN 30 08-20 |
DI 23022.975 |
Peritoneal Mucinous Carcinomatosis |
TN 33 08-20 |
DI 23022.977 |
Phelan-McDermid Syndrome |
TN 54 09-22 |
DI 23022.979 |
Retinopathy of Prematurity - Stage V, Bilateral |
TN 33 08-20 |
DI 23022.981 |
Roberts Syndrome |
TN 49 10-21 |
DI 23022.983 |
Severe Combined Immunodeficiency -- Childhood |
TN 33 08-20 |
DI 23022.985 |
Sinonasal Cancer |
TN 33 08-20 |
DI 23022.987 |
Transplant Coronary Artery Vasculopathy |
TN 36 09-20 |
DI 23022.989 |
Usher Syndrome - Type I |
TN 36 09-20 |